ProShare Advisors’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
15,365
+2,319
| +18% | +$18.9K | ﹤0.01% | 1827 |
|
|
2025
Q1 | $102K | Sell |
13,046
-3,333
| -20% | -$26.2K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $244K | Buy |
16,379
+5,038
| +44% | +$75K | ﹤0.01% | 1778 |
|
|
2024
Q3 | $173K | Buy |
+11,341
| New | +$173K | ﹤0.01% | 1766 |
|
|
2024
Q2 | – | Sell |
-10,846
| Closed | -$205K | – | 1969 |
|
|
2024
Q1 | $205K | Buy |
10,846
+746
| +7% | +$14.1K | ﹤0.01% | 1656 |
|
|
2023
Q4 | $193K | Buy |
+10,100
| New | +$193K | ﹤0.01% | 1648 |
|
|
2022
Q2 | – | Sell |
-8,410
| Closed | -$266K | – | 2055 |
|
|
2022
Q1 | $266K | Sell |
8,410
-1,365
| -14% | -$43.2K | ﹤0.01% | 1713 |
|
|
2021
Q4 | $396K | Buy |
9,775
+3,968
| +68% | +$161K | ﹤0.01% | 1615 |
|
|
2021
Q3 | $202K | Sell |
5,807
-5,947
| -51% | -$207K | ﹤0.01% | 1790 |
|
|
2021
Q2 | $323K | Buy |
11,754
+493
| +4% | +$13.5K | ﹤0.01% | 1849 |
|
|
2021
Q1 | $316K | Buy |
11,261
+1,923
| +21% | +$54K | ﹤0.01% | 1776 |
|
|
2020
Q4 | $242K | Buy |
+9,338
| New | +$242K | ﹤0.01% | 1748 |
|